Product Information
ERYTHROMYCIN DR 333 MG TABLET is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $3.5039 per EA under NDC 52536018303. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
333 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536018303
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062298On Market Since
7/22/2019
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 333 MG TABLET has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5039 per EA |
|---|---|
| All-time high | $3.9058 (Dec 11, 2024) |
| All-time low | $2.5179 (Aug 21, 2024) |
| 52-week high | $3.7275 |
| 52-week low | $3.3321 |
| Median price | $3.4234 |
| Average price | $3.3854 |
| Largest weekly change | +47.3% (Nov 20, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 333 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 333 MG TABLET, manufactured by Wilshire Pharmaceuticals Inc., is $3.5039 per EA (NDC 52536018303), effective Jun 24, 2026.
How has the price of ERYTHROMYCIN DR 333 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has risen 3.2%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 333 MG TABLET?
Since Apr 17, 2024, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has ranged from a low of $2.5179 (Aug 21, 2024) to a high of $3.9058 (Dec 11, 2024), with a median of $3.4234 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 333 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ERYTHROMYCIN DR 333 MG TABLET, but none are currently priced below it.
Who manufactures ERYTHROMYCIN DR 333 MG TABLET?
ERYTHROMYCIN DR 333 MG TABLET (NDC 52536018303) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification